AMN at a glance
AMN HEALTHCARE SERVICES INC (AMN, SEC CIK 1142750) filed its latest 10-K annual report on February 20, 2026, a 10-Q quarterly report on August 7, 2026, an 8-K current report on August 6, 2026 and Form 4 insider filings as recently as September 16, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), AMN HEALTHCARE SERVICES INC (AMN) reported revenue of $2.7 billion (down 8.5% from FY2024) and a net loss of $95.7 million. Diluted EPS was -$2.48.
- As of June 30, 2026, 30 institutional investment managers tracked by SignalX reported holding AMN HEALTHCARE SERVICES INC (AMN) shares worth $785.4 million in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by FOLETTA MARK G on June 15, 2026 of 2,000 shares at $31.07 per share.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $2.7B
- −8.5% vs prior year
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 30 funds
- $785.4M · +0 vs prior quarter
- Latest 8-K
- Aug 6, 2026
- Item 2.02
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jun 30, 2026
Management Discussion & Analysis
- Q2 revenue $673.2M, up 2% YoY from $658.2M, driven by nurse and allied solutions
- Nurse and allied revenue $422.0M, up 11%; technology and workforce revenue $86.7M, down 15%
- Gross margin 30.6% vs 29.8%; operating margin 4.0% vs (18.8%) YoY
- Operating cash flow $372.5M versus $171.2M; cash increased $323.3M
- Headwinds: language-services pricing pressure, VMS volume declines, and lower locum-tenens days filled
Risk Factors
- Risk Factors section not provided; no new or changed risks identifiable
- Repurchase-program cash use: $2.3 million spent during six months ended June 30, 2026
- Remaining repurchase authorization: $224.4 million as of June 30, 2026
AI summary of the AMN 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 2.02: Results of Operations and Financial Condition
- Q2 fiscal 2026 results reported for quarter ended June 30, 2026
- Full financial results and management commentary contained in Exhibit 99.1
Item EX-99.1: Item EX-99.1
- Q2 revenue $673.2M, up 2%; adjusted EBITDA $73.4M, up 26%, with margin reaching 10.9%
- GAAP diluted EPS $0.53 versus $(3.02); adjusted EPS $0.77 versus $0.30, reflecting significant earnings normalization
Item 2.02: Results of Operations and Financial Condition
- Q1 2026 results released for quarter ended March 31, 2026
- Full financial results and management commentary available in Exhibit 99.1
Item 5.02: Departure/Appointment of Directors or Principal Officers
- Shareholders approved Amendment No. 1 to the AMN Healthcare 2025 Equity Plan on May 1, 2026
- Approval enables the amended equity plan, potentially affecting future employee and executive share-based compensation
Item 5.07: Submission of Matters to a Vote of Security Holders
- All nine director nominees elected, preserving existing board composition through the next annual meeting
- Executive compensation received advisory approval, with 22,728,186 votes for versus 7,071,111 against
AI summaries of AMN 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for AMN
Don't miss the next AMN filing
- Alerts as it files. A push when AMN files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut AMN, by share count.
- Ask anything. An AI agent that reads every AMN filing and answers with sources.
AMN alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Laughlin Whitney M | M | Sep 15, 2026 | 498 | - |
| Laughlin Whitney M | M | Sep 15, 2026 | 498 | - |
| Laughlin Whitney M | F | Sep 15, 2026 | 122 | $34.19 |
| FOLETTA MARK G | Sell | Jun 15, 2026 | 2,000 | $31.07 |
| FOLETTA MARK G | Sell | Jun 15, 2026 | 1,681 | $31.07 |
| Trent-Adams Sylvia | A | May 1, 2026 | 8,304 | - |
| Trent-Adams Sylvia | M | May 1, 2026 | 8,325 | - |
| Fontenot Teri G. | A | May 1, 2026 | 8,304 | - |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $3.0B | $2.7B |
| Gross Profit | - | $919.4M | $774.1M |
| Operating Income | - | -$102.7M | -$55.5M |
| Net Income | - | -$147.0M | -$95.7M |
| Gross Margin | - | 30.8% | 28.3% |
| Op. Margin | - | -3.4% | -2.0% |
| Net Margin | - | -4.9% | -3.5% |
| Balance Sheet | |||
| Total Assets | $2.9B | $2.4B | $2.1B |
| Equity | $831.3M | $706.6M | $642.1M |
| ROE | - | -20.8% | -14.9% |
| Per Share | |||
| EPS | - | $-3.85 | $-2.48 |
| Cash Flow | |||
| Operating CF | - | $320.4M | $269.5M |
| CapEx | - | $80.9M | $35.6M |
Source: XBRL data in AMN HEALTHCARE SERVICES INC (AMN)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate AMN share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 30 | $785.4M |
| Q1 2026 | 30 | $404.7M |
| Q4 2025 | 27 | $347.4M |
| Q3 2025 | 28 | $425.5M |
| Q2 2025 | 28 | $463.1M |
| Q1 2025 | 24 | $381.5M |
| Q4 2024 | 22 | $334.3M |
| Q3 2024 | 21 | $223.8M |
- Ameriprise Financial+969.3K (+1184%)
- Morgan Stanley+941.9K (+70%)
- T. Rowe Price Group+686.8K (+1211%)
- BlackRock+619.9K (+10%)
- Dimensional Fund Advisors+542.2K (+73%)
- Two Sigma Investments−429.4K (-27%)
- JPMorgan Chase & Co−348.1K (-82%)
- D.E. Shaw & Co−340.5K (-38%)
- Renaissance Technologies LLC−279.8K (-20%)
- Citadel Advisors LLC−274.8K (-73%)
- Mangrove Partners+53.4K
- Millennium Management−997.3K
Source: 13F-HR filings on SEC EDGAR (aggregated from 210 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
AMN filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-Q quarterly reports
8-K current reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Sep 16, 2026 | - | - | - |
| SC 13G | Aug 13, 2026 | - | - | |
| 10-Q | Aug 7, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Aug 6, 2026 | - | Analysis | - |
| 4 | Jul 9, 2026 | - | - | - |
| 4 | Jun 17, 2026 | - | - | - |
| 10-Q | May 8, 2026 | Mar 31, 2026 | Analysis | |
| 8-K | May 7, 2026 | - | Analysis | |
| 4 | May 4, 2026 | - | - | - |
| 4 | May 4, 2026 | - | - | - |
| 4 | May 4, 2026 | - | - | - |
| 4 | May 4, 2026 | - | - | - |
| 4 | May 4, 2026 | - | - | - |
| 4 | May 4, 2026 | - | - | - |
| 4 | May 4, 2026 | - | - | - |
| 8-K | May 4, 2026 | - | Analysis | - |
| 4 | May 4, 2026 | - | - | - |
| 4 | May 4, 2026 | - | - | - |
| SC 13G | Apr 29, 2026 | - | - | |
| 10-K | Feb 20, 2026 | Dec 31, 2025 | - | |
| 8-K | Feb 19, 2026 | - | - | |
| 8-K | Feb 5, 2026 | - | - | |
| 4 | Jan 30, 2026 | - | - | |
| 4 | Jan 30, 2026 | - | - | |
| 4 | Jan 30, 2026 | - | - |
Related Information Technology companies
- ASGN · ASGN IncServices-Help Supply Services
- BBSI · BARRETT BUSINESS SERVICES INCServices-Help Supply Services
- CCRN · CROSS COUNTRY HEALTHCARE INCServices-Help Supply Services
- NSP · INSPERITY, INC.Services-Help Supply Services
- KELYA · KELLY SERVICES INCServices-Help Supply Services
- KFRC · KFORCE INCServices-Help Supply Services
- RCMT · RCM TECHNOLOGIES, INC.Services-Help Supply Services
- TBI · TrueBlue, Inc.Services-Help Supply Services
AMN SEC filings: frequently asked questions
Which institutions hold AMN stock?
As of June 30, 2026, the largest AMN HEALTHCARE SERVICES INC (AMN) holders among the 13F filers tracked by SignalX were BlackRock ($215.0 million), Morgan Stanley ($73.9 million), Vanguard Capital Management LLC ($55.6 million), State Street Corp ($54.8 million), Vanguard Portfolio Management LLC ($41.7 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was AMN's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), AMN HEALTHCARE SERVICES INC (AMN) reported revenue of $2.7 billion (down 8.5% from FY2024) and a net loss of $95.7 million. Diluted EPS was -$2.48. The figures come from the XBRL data in the 10-K.
What did AMN report in its latest 8-K?
AMN HEALTHCARE SERVICES INC (AMN) filed an 8-K on August 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q2 fiscal 2026 results reported for quarter ended June 30, 2026.
What are the latest AMN SEC filings?
AMN HEALTHCARE SERVICES INC (AMN) filed its latest 10-K annual report on February 20, 2026, a 10-Q quarterly report on August 7, 2026, an 8-K current report on August 6, 2026 and a Form 4 insider filing on September 16, 2026.
What is AMN's SEC CIK number?
AMN HEALTHCARE SERVICES INC (AMN)'s SEC Central Index Key (CIK) is 1142750. EDGAR lists every AMN filing under that number.
Ask anything about AMN
The research agent reads AMN's filings, financials, insider trades and 13F holders, then answers with sources.